TherapeuticsMD (TXMD)
NASDAQ:TXMD
Holding TXMD?
Track your performance easily

TherapeuticsMD (TXMD) Ownership - Who Owns TherapeuticsMD?

2,225 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 26, 2024
xxxxxxxxxxxxx
$7083
Aug 23, 2024
xxxxxxxxxxxxx
$2028

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
587,854Insider5.10%1,005,230
371,891Institution3.22%635,934
371,891Institution3.22%635,934
106,864Insider0.93%182,737
76,673Institution0.66%131,111
61,853Insider0.54%105,769
52,016Insider0.45%88,947
40,000Insider0.35%68,400
34,000Institution0.29%58,140
20,287Insider0.18%34,691

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
371,891Institution3.22%635,934
76,673Institution0.66%131,111
34,000Institution0.29%58,140
10,380Institution0.09%17,750
8,000Institution0.07%13,680
7,345Institution0.06%12,560
7,060Institution0.06%12,073
5,486Institution0.05%9,381
5,268Institution0.05%9,008
4,000Institution0.03%6,840

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
249,657Institution2.16%434,403
122,234Institution1.06%212,687

FAQ

Who Owns TherapeuticsMD (TXMD)?
Currently, no data Available
What percentage of TherapeuticsMD (TXMD) stock is held by institutional investors?
Currently, no data Available
What percentage of TherapeuticsMD (TXMD) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of TherapeuticsMD (TXMD)?
Nicholas Segal owns the most shares of TherapeuticsMD (TXMD).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis